| Investment [Table Text Block] |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Non-Affiliate Investments — 183.3% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Non-Affiliate Debt Investments — 175.4% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Non-Affiliate Debt Investments — Life Science — 85.2% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Castle Creek Biosciences, Inc. (2)(12) | | Biotechnology | | Term Loan | | | 12.00 | % | | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 4.00 | % | | March 1, 2028 | | | 10,000 | | | | 9,947 | | | | 9,947 | |
| | | | | Term Loan | | | 12.00 | % | | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 4.00 | % | | March 1, 2028 | | | 5,500 | | | | 5,471 | | | | 5,471 | |
| | | | | Term Loan | | | 12.00 | % | | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 4.00 | % | | March 1, 2028 | | | 5,000 | | | | 4,974 | | | | 4,974 | |
| | | | | Term Loan | | | 12.00 | % | | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 4.00 | % | | March 1, 2028 | | | 5,000 | | | | 4,974 | | | | 4,974 | |
| Emalex Biosciences, Inc. (2)(12) | | Biotechnology | | Term Loan | | | 11.47 | % | | Prime | | | 4.72 | % | | | 9.75 | % | | | — | | | | 5.00 | % | | May 1, 2026 | | | 1,667 | | | | 1,665 | | | | 1,665 | |
| KSQ Therapeutics, Inc. (2)(12) | | Biotechnology | | Term Loan | | | 10.75 | % | | Prime | | | 3.75 | % | | | 10.75 | % | | | — | | | | 5.00 | % | | April 1, 2030 | | | 4,250 | | | | 4,237 | | | | 4,237 | |
| | | | | Term Loan | | | 10.75 | % | | Prime | | | 3.75 | % | | | 10.75 | % | | | — | | | | 5.00 | % | | April 1, 2030 | | | 4,250 | | | | 4,237 | | | | 4,237 | |
| | | | | Term Loan | | | 10.75 | % | | Prime | | | 3.75 | % | | | 10.75 | % | | | — | | | | 5.00 | % | | April 1, 2030 | | | 4,250 | | | | 4,237 | | | | 4,237 | |
| | | | | Term Loan | | | 10.75 | % | | Prime | | | 3.75 | % | | | 10.75 | % | | | — | | | | 5.00 | % | | April 1, 2030 | | | 4,250 | | | | 4,237 | | | | 4,237 | |
| Long Grove Pharmaceuticals, LLC (2)(12) | | Biotechnology | | Term Loan | | | 7.87 | % (11) | | 1-month SOFR | | | 4.00 | % | | | 6.00 | % | | | — | | | | — | | | February 27, 2031 | | | 10,298 | | | | 10,086 | | | | 10,086 | |
| Provivi, Inc. (2)(12)(13) | | Biotechnology | | Term Loan | | | 12.11 | % (11) | | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.30 | % | | January 1, 2027 | | | 1,906 | | | | 1,683 | | | | 924 | |
| | | | | Term Loan | | | 12.11 | % (11) | | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.30 | % | | January 1, 2027 | | | 1,906 | | | | 1,683 | | | | 924 | |
| | | | | Term Loan | | | 12.11 | % (11) | | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.31 | % | | January 1, 2027 | | | 953 | | | | 838 | | | | 460 | |
| | | | | Term Loan | | | 12.11 | % (11) | | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.31 | % | | January 1, 2027 | | | 953 | | | | 838 | | | | 460 | |
| | | | | Term Loan | | | 12.11 | % (11) | | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.31 | % | | January 1, 2027 | | | 953 | | | | 838 | | | | 460 | |
| | | | | Term Loan | | | 12.11 | % (11) | | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.31 | % | | January 1, 2027 | | | 953 | | | | 838 | | | | 460 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Ceribell, Inc. (2)(5)(12) | | Medical Device | | Term Loan | | | 9.50 | % | | Prime | | | 2.75 | % | | | 9.25 | % | | | — | | | | 4.00 | % | | March 1, 2029 | | | 5,000 | | | | 4,833 | | | | 4,833 | |
| | | | | Term Loan | | | 9.50 | % | | Prime | | | 2.75 | % | | | 9.25 | % | | | — | | | | 4.00 | % | | March 1, 2029 | | | 5,000 | | | | 4,954 | | | | 4,954 | |
| | | | | Term Loan | | | 9.50 | % | | Prime | | | 2.75 | % | | | 9.25 | % | | | — | | | | 4.00 | % | | March 1, 2029 | | | 4,000 | | | | 3,963 | | | | 3,963 | |
| Conventus Orthopaedics, Inc. (2)(12) | | Medical Device | | Term Loan | | | 13.07 | % | | Prime | | | 6.32 | % | | | 10.75 | % | | | — | | | | 10.88 | % | | July 1, 2026 | | | 2,801 | | | | 2,785 | | | | 2,785 | |
| | | | | Term Loan | | | 13.07 | % | | Prime | | | 6.32 | % | | | 10.75 | % | | | — | | | | 10.88 | % | | July 1, 2026 | | | 2,801 | | | | 2,785 | | | | 2,785 | |
| Infobionic, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.00 | % | | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 2.00 | % | | September 1, 2029 | | | 5,000 | | | | 4,937 | | | | 4,937 | |
| | | | | Term Loan | | | 12.00 | % | | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 2.00 | % | | September 1, 2029 | | | 5,000 | | | | 4,937 | | | | 4,937 | |
| | | | | Term Loan | | | 12.00 | % | | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 2.00 | % | | September 1, 2029 | | | 5,000 | | | | 4,937 | | | | 4,937 | |
| | | | | Term Loan | | | 12.00 | % | | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 4.00 | % | | September 1, 2029 | | | 2,500 | | | | 2,379 | | | | 2,379 | |
| | | | | Term Loan | | | 12.00 | % | | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 4.00 | % | | September 1, 2029 | | | 2,500 | | | | 2,429 | | | | 2,429 | |
| Mobia Medical, Inc. fka Microtransponder, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.25 | % | | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 3.50 | % | | January 1, 2029 | | | 3,750 | | | | 3,710 | | | | 3,710 | |
| | | | | Term Loan | | | 12.25 | % | | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 3.50 | % | | January 1, 2029 | | | 3,750 | | | | 3,710 | | | | 3,710 | |
| MML US, Inc. (2)(12) | | Medical Device | | Term Loan | | | 10.00 | % (11) | | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | | March 1, 2030 | | | 2,565 | | | | 2,444 | | | | 2,444 | |
| | | | | Term Loan | | | 10.00 | % (11) | | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | | March 1, 2030 | | | 2,565 | | | | 2,543 | | | | 2,543 | |
| | | | | Term Loan | | | 10.00 | % (11) | | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | | March 1, 2030 | | | 5,129 | | | | 5,086 | | | | 5,086 | |
| | | | | Term Loan | | | 10.00 | % (11) | | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | | March 1, 2030 | | | 5,129 | | | | 5,086 | | | | 5,086 | |
| | | | | Term Loan | | | 10.00 | % (11) | | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | | March 1, 2030 | | | 5,091 | | | | 5,046 | | | | 5,046 | |
| | | | | Term Loan | | | 10.00 | % (11) | | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | | March 1, 2030 | | | 5,091 | | | | 5,046 | | | | 5,046 | |
| Onkos Surgical, Inc. (2)(12) | | Medical Device | | Term Loan | | | 10.75 | % | | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | | January 1, 2030 | | | 10,000 | | | | 9,874 | | | | 9,874 | |
| | | | | Term Loan | | | 10.75 | % | | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | | January 1, 2030 | | | 10,000 | | | | 9,874 | | | | 9,874 | |
| | | | | Term Loan | | | 10.75 | % | | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | | January 1, 2030 | | | 5,000 | | | | 4,937 | | | | 4,937 | |
| | | | | Term Loan | | | 10.75 | % | | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | | January 1, 2030 | | | 5,000 | | | | 4,937 | | | | 4,937 | |
| | | | | Term Loan | | | 10.75 | % | | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | | October 1, 2030 | | | 5,000 | | | | 4,926 | | | | 4,926 | |
| Scientia Vascular, Inc. (2)(12) | | Medical Device | | Term Loan | | | 10.25 | % | | Prime | | | 2.75 | % | | | 10.25 | % | | | — | | | | 4.00 | % | | July 1, 2030 | | | 10,000 | | | | 9,890 | | | | 9,890 | |
| | | | | Term Loan | | | 10.25 | % | | Prime | | | 2.75 | % | | | 10.25 | % | | | — | | | | 4.00 | % | | July 1, 2030 | | | 10,000 | | | | 9,890 | | | | 9,890 | |
| | | | | Term Loan | | | 10.25 | % | | Prime | | | 2.75 | % | | | 10.25 | % | | | — | | | | 4.00 | % | | July 1, 2030 | | | 5,000 | | | | 4,945 | | | | 4,945 | |
| | | | | Term Loan | | | 10.25 | % | | Prime | | | 2.75 | % | | | 10.25 | % | | | — | | | | 4.00 | % | | July 1, 2030 | | | 1,500 | | | | 1,483 | | | | 1,483 | |
| | | | | Term Loan | | | 10.25 | % | | Prime | | | 2.75 | % | | | 10.25 | % | | | — | | | | 4.00 | % | | July 1, 2030 | | | 3,500 | | | | 3,459 | | | | 3,459 | |
| Sonex Health, Inc. (2)(12) | | Medical Device | | Term Loan | | | 11.75 | % | | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | | September 1, 2027 | | | 2,500 | | | | 2,489 | | | | 2,489 | |
| | | | | Term Loan | | | 11.75 | % | | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | | September 1, 2027 | | | 2,500 | | | | 2,489 | | | | 2,489 | |
| | | | | Term Loan | | | 11.75 | % | | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | | September 1, 2027 | | | 5,000 | | | | 4,977 | | | | 4,977 | |
| | | | | Term Loan | | | 11.75 | % | | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | | September 1, 2027 | | | 5,000 | | | | 4,977 | | | | 4,977 | |
| | | | | Term Loan | | | 11.75 | % | | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | | April 1, 2028 | | | 3,750 | | | | 3,725 | | | | 3,725 | |
| | | | | Term Loan | | | 11.75 | % | | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | | April 1, 2028 | | | 3,750 | | | | 3,725 | | | | 3,725 | |
| | | | | Term Loan | | | 11.75 | % | | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | | April 1, 2028 | | | 3,750 | | | | 3,725 | | | | 3,725 | |
| | | | | Term Loan | | | 11.75 | % | | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | | April 1, 2028 | | | 3,750 | | | | 3,725 | | | | 3,725 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Spineology, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.00 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 1.00 | % | | August 1, 2029 | | | 5,000 | | | | 4,936 | | | | 4,936 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 1.00 | % | | August 1, 2029 | | | 4,250 | | | | 4,195 | | | | 4,195 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 1.00 | % | | August 1, 2029 | | | 4,250 | | | | 4,196 | | | | 4,196 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 1.00 | % | | August 1, 2029 | | | 2,500 | | | | 2,468 | | | | 2,468 | |
| Vero Biotech, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 4.00 | % | | January 1, 2029 | | | 15,000 | | | | 14,803 | | | | 14,803 | |
| | | | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 4.00 | % | | January 1, 2029 | | | 10,000 | | | | 9,869 | | | | 9,869 | |
| | | | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 4.00 | % | | January 1, 2029 | | | 5,000 | | | | 4,933 | | | | 4,933 | |
| | | | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 4.00 | % | | January 1, 2029 | | | 2,500 | | | | 2,466 | | | | 2,466 | |
| Total Non-Affiliate Debt Investments — Life Science | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 274,306 | | | | 271,276 | |
| Non-Affiliate Debt Investments — Sustainability — 1.5% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| SparkCharge, Inc. (2)(12) | | Alternative Energy | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 5.00 | % | | May 1, 2029 | | | 2,500 | | | | 2,398 | | | | 2,398 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 5.00 | % | | May 1, 2029 | | | 2,500 | | | | 2,471 | | | | 2,471 | |
| Total Non-Affiliate Debt Investments — Sustainability | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 4,869 | | | | 4,869 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Non-Affiliate Debt Investments — Technology — 63.3% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Havenly, Inc. (2)(12) | | Consumer-related Technologies | | Term Loan | | | 11.75 | % | Prime | | | 5.00 | % | | | 5.00 | % | | | — | | | | 10.40 | % | | March 1, 2027 | | | 1,111 | | | | 982 | | | | 982 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 5.00 | % | | | 5.00 | % | | | — | | | | 10.40 | % | | March 1, 2027 | | | 1,667 | | | | 1,482 | | | | 1,482 | |
| | | | | Term Loan (17) | | | 10.50 | % | Prime | | | 3.50 | % | | | 10.50 | % | | | — | | | | 7.78 | % | | February 1, 2028 | | | 3,375 | | | | 1,915 | | | | 3,374 | |
| | | | | Term Loan | | | 10.50 | % | Prime | | | 3.50 | % | | | 10.50 | % | | | — | | | | 7.78 | % | | February 1, 2028 | | | 2,813 | | | | 2,813 | | | | 2,813 | |
| | | | | Term Loan | | | 10.50 | % | Prime | | | 3.50 | % | | | 10.50 | % | | | — | | | | 7.78 | % | | February 1, 2028 | | | 2,813 | | | | 2,813 | | | | 2,813 | |
| Lyrical Foods, Inc. (2)(12) | | Consumer-related Technologies | | Term Loan | | | 10.25 | % | Prime | | | 3.50 | % | | | 9.00 | % | | | — | | | | 5.00 | % | | July 1, 2028 | | | 2,679 | | | | 2,771 | | | | 2,400 | |
| | | | | Term Loan (17) | | | 10.25 | % | Prime | | | 3.50 | % | | | 9.00 | % | | | — | | | | 5.00 | % | | July 1, 2028 | | | 2,679 | | | | 1,286 | | | | 2,320 | |
| Apkudo, Inc. (2)(12) | | Software | | Term Loan | | | 11.25 | % | Prime | | | 4.25 | % | | | 7.00 | % | | | — | | | | 3.00 | % | | October 1, 2029 | | | 5,000 | | | | 4,908 | | | | 4,908 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 4.25 | % | | | 7.00 | % | | | — | | | | 3.00 | % | | October 1, 2029 | | | 5,000 | | | | 4,908 | | | | 4,908 | |
| BriteCore Holdings, Inc. (2)(12) | | Software | | Term Loan | | | 10.50 | % | Prime | | | 3.75 | % | | | 6.50 | % | | | — | | | | 3.00 | % | | January 1, 2031 | | | 10,000 | | | | 9,831 | | | | 9,831 | |
| | | | | Term Loan | | | 10.50 | % | Prime | | | 3.75 | % | | | 6.50 | % | | | — | | | | 3.00 | % | | January 1, 2031 | | | 7,500 | | | | 7,410 | | | | 7,410 | |
| | | | | Term Loan | | | 10.50 | % | Prime | | | 3.75 | % | | | 6.50 | % | | | — | | | | 3.00 | % | | January 1, 2031 | | | 2,500 | | | | 2,470 | | | | 2,470 | |
| Crafty Holdings, Inc. (2)(12) | | Software | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 4.00 | % | | January 1, 2029 | | | 5,000 | | | | 4,894 | | | | 4,894 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 4.00 | % | | January 1, 2029 | | | 5,000 | | | | 4,933 | | | | 4,933 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 4.00 | % | | January 1, 2029 | | | 5,000 | | | | 4,933 | | | | 4,933 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 4.00 | % | | January 1, 2029 | | | 2,000 | | | | 1,969 | | | | 1,969 | |
| Dropoff, Inc. (2)(12) | | Software | | Term Loan (17) | | | 13.25 | % | Prime | | | 6.50 | % | | | 9.75 | % | | | — | | | | 3.50 | % | | June 1, 2026 | | | 7,850 | | | | 2,450 | | | | 4,411 | |
| | | | | Term Loan | | | 13.25 | % | Prime | | | 6.50 | % | | | 9.75 | % | | | — | | | | 3.50 | % | | June 1, 2026 | | | 6,804 | | | | 6,785 | | | | 3,813 | |
| | | | | Term Loan | | | 13.25 | % | Prime | | | 6.50 | % | | | 9.75 | % | | | — | | | | 3.50 | % | | June 1, 2026 | | | 6,280 | | | | 6,263 | | | | 3,520 | |
| | | | | Term Loan | | | 13.25 | % | Prime | | | 6.50 | % | | | 9.75 | % | | | — | | | | 3.50 | % | | June 1, 2026 | | | 2,617 | | | | 2,613 | | | | 1,468 | |
| HappyCo, Inc. (2)(12) | | Software | | Term Loan | | | 11.13 | % | Prime | | | 3.75 | % | | | 11.00 | % | | | — | | | | 2.75 | % | | February 1, 2030 | | | 3,000 | | | | 2,969 | | | | 2,969 | |
| | | | | Term Loan | | | 11.13 | % | Prime | | | 3.75 | % | | | 11.00 | % | | | — | | | | 2.75 | % | | February 1, 2030 | | | 3,000 | | | | 2,969 | | | | 2,969 | |
| | | | | Term Loan | | | 11.13 | % | Prime | | | 3.75 | % | | | 11.00 | % | | | — | | | | 2.75 | % | | February 1, 2030 | | | 2,000 | | | | 1,978 | | | | 1,978 | |
| | | | | Term Loan | | | 11.13 | % | Prime | | | 3.75 | % | | | 11.00 | % | | | — | | | | 2.75 | % | | February 1, 2030 | | | 2,000 | | | | 1,975 | | | | 1,975 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Kodiak Robotics, Inc. (2)(12) | | Software | | Term Loan | | | 10.25 | % | Prime | | | 3.50 | % | | | 6.50 | % | | | — | | | | 4.00 | % | | January 1, 2030 | | | 15,000 | | | | 14,599 | | | | 14,599 | |
| | | | | Term Loan | | | 10.25 | % | Prime | | | 3.50 | % | | | 6.50 | % | | | — | | | | 4.00 | % | | January 1, 2030 | | | 7,500 | | | | 7,300 | | | | 7,300 | |
| | | | | Term Loan | | | 10.25 | % | Prime | | | 3.50 | % | | | 6.50 | % | | | — | | | | 4.00 | % | | January 1, 2030 | | | 7,500 | | | | 7,300 | | | | 7,300 | |
| MasteryPrep, LLC (2)(12) | | Software | | Term Loan | | | 11.50 | % | Prime | | | 4.00 | % | | | 11.50 | % | | | — | | | | 3.75 | % | | July 1, 2029 | | | 7,500 | | | | 7,383 | | | | 7,383 | |
| | | | | Term Loan | | | 11.50 | % | Prime | | | 4.00 | % | | | 11.50 | % | | | — | | | | 3.75 | % | | July 1, 2029 | | | 7,500 | | | | 7,433 | | | | 7,433 | |
| Mirantis, Inc. (2)(12) | | Software | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | | October 1, 2028 | | | 4,583 | | | | 4,541 | | | | 4,541 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | | October 1, 2028 | | | 4,583 | | | | 4,541 | | | | 4,541 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | | October 1, 2028 | | | 4,583 | | | | 4,541 | | | | 4,541 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | | October 1, 2028 | | | 4,583 | | | | 4,541 | | | | 4,541 | |
| Samba TV, Inc. (2)(12) | | Software | | Term Loan | | | 10.25 | % (11) | Prime | | | 3.50 | % | | | 3.50 | % | | | — | | | | 4.00 | % | | December 1, 2030 | | | 10,014 | | | | 9,792 | | | | 9,792 | |
| | | | | Term Loan | | | 10.25 | % (11) | Prime | | | 3.50 | % | | | 3.50 | % | | | — | | | | 4.00 | % | | December 1, 2030 | | | 7,510 | | | | 7,400 | | | | 7,400 | |
| | | | | Term Loan | | | 10.25 | % (11) | Prime | | | 3.50 | % | | | 3.50 | % | | | — | | | | 4.00 | % | | December 1, 2030 | | | 5,007 | | | | 4,934 | | | | 4,934 | |
| | | | | Term Loan | | | 10.25 | % (11) | Prime | | | 3.50 | % | | | 3.50 | % | | | — | | | | 4.00 | % | | December 1, 2030 | | | 2,503 | | | | 2,467 | | | | 2,467 | |
| Supply Network Visibility Holdings LLC (2)(12) | | Software | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | | June 1, 2028 | | | 2,500 | | | | 2,435 | | | | 2,280 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | | June 1, 2028 | | | 3,500 | | | | 3,495 | | | | 3,273 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | | June 1, 2028 | | | 2,500 | | | | 2,496 | | | | 2,338 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | | June 1, 2028 | | | 1,500 | | | | 1,498 | | | | 1,403 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | | July 1, 2029 | | | 5,000 | | | | 4,988 | | | | 4,671 | |
| Ursa Space Systems, Inc. (2)(12) | | Software | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | | November 1, 2028 | | | 2,500 | | | | 2,460 | | | | 2,460 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | | November 1, 2028 | | | 2,500 | | | | 2,460 | | | | 2,460 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | | November 1, 2028 | | | 2,500 | | | | 2,445 | | | | 2,445 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | | November 1, 2028 | | | 2,500 | | | | 2,445 | | | | 2,445 | |
| Viken Detection Corporation (2)(12) | | Software | | Term Loan | | | 11.75 | % | Prime | | | 4.00 | % | | | 11.75 | % | | | — | | | | 3.50 | % | | June 1, 2027 | | | 2,833 | | | | 2,814 | | | | 2,814 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 4.00 | % | | | 11.75 | % | | | — | | | | 3.50 | % | | June 1, 2027 | | | 1,417 | | | | 1,407 | | | | 1,407 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 4.00 | % | | | 11.75 | % | | | — | | | | 3.50 | % | | June 1, 2027 | | | 1,417 | | | | 1,407 | | | | 1,407 | |
| Total Non-Affiliate Debt Investments — Technology | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 205,442 | | | | 201,718 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Non-Affiliate Debt Investments — Healthcare information and services — 25.4% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| BrightInsight, Inc. (2)(12) | | Software | | Term Loan (17) | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | | August 1, 2027 | | | 5,500 | | | | 2,905 | | | | 5,105 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | | August 1, 2027 | | | 6,417 | | | | 6,398 | | | | 5,939 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | | August 1, 2027 | | | 3,208 | | | | 3,199 | | | | 2,969 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | | August 1, 2027 | | | 3,208 | | | | 3,199 | | | | 2,969 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | | August 1, 2027 | | | 2,750 | | | | 2,731 | | | | 2,535 | |
| | | | | Term Loan (17) | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | | August 1, 2027 | | | 2,250 | | | | 1,277 | | | | 2,089 | |
| Elligo Health Research, Inc. (2)(12) | | Software | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | | October 1, 2027 | | | 10,000 | | | | 9,936 | | | | 9,936 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | | October 1, 2027 | | | 5,000 | | | | 4,968 | | | | 4,968 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | | October 1, 2027 | | | 5,000 | | | | 4,968 | | | | 4,968 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | | October 1, 2027 | | | 5,000 | | | | 4,968 | | | | 4,968 | |
| GT Medical Technologies, Inc. (2)(12) | | Other Healthcare Services | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 4.00 | % | | October 1, 2029 | | | 3,750 | | | | 3,604 | | | | 3,604 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 4.00 | % | | October 1, 2029 | | | 3,750 | | | | 3,705 | | | | 3,705 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 4.00 | % | | October 1, 2029 | | | 7,500 | | | | 7,409 | | | | 7,409 | |
| Hometeam Technologies, Inc. (2)(12)(13) | | Other Healthcare Services | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | | August 1, 2029 | | | 4,821 | | | | 4,781 | | | | 3,967 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | | August 1, 2029 | | | 4,821 | | | | 4,781 | | | | 3,967 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | | August 1, 2029 | | | 4,821 | | | | 4,682 | | | | 3,883 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | | August 1, 2029 | | | 4,821 | | | | 4,781 | | | | 3,967 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | | August 1, 2029 | | | 4,821 | | | | 4,781 | | | | 3,967 | |
| Total Non-Affiliate Debt Investments — Healthcare information and services | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 83,073 | | | | 80,915 | |
| Total Non- Affiliate Debt Investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 567,690 | | | $ | 558,778 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Non-Affiliate Warrant Investments — 5.2% (8) | | | | | | | | | | | | | | | | |
| Non-Affiliate Warrants — Life Science — 2.2% (8) | | | | | | | | | | | | | | | | |
| Avalo Therapeutics, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 149 | | | | 311 | | | | — | |
| BioVaxys Technology Corp. (5)(12) | | Biotechnology | | Common Stock Warrant | | | 400,000 | | | | 5 | | | | — | |
| Castle Creek Biosciences, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 13,821 | | | | 372 | | | | 274 | |
| Emalex Biosciences, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 110,402 | | | | 176 | | | | 447 | |
| Imunon, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 19,671 | | | | 65 | | | | — | |
| KSQ Therapeutics, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 134,614 | | | | 138 | | | | 13 | |
| Mustang Bio, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 568 | | | | 146 | | | | — | |
| Native Microbials, Inc (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 178,631 | | | | 93 | | | | 4 | |
| PDS Biotechnology Corporation (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 381,625 | | | | 161 | | | | — | |
| Provivi, Inc. (2)(12) | | Biotechnology | | Common Stock Warrant | | | 175,098 | | | | 278 | | | | — | |
| Provivi, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 709,980 | | | | 312 | | | | — | |
| Stealth Biotherapeutics Inc. (2)(12) | | Biotechnology | | Common Stock Warrant | | | 454,544 | | | | 266 | | | | 6 | |
| Xeris Pharmaceuticals, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 126,000 | | | | 73 | | | | 691 | |
| Aerin Medical, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 1,818,183 | | | | 66 | | | | 1,333 | |
| Canary Medical Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 12,153 | | | | 86 | | | | — | |
| Ceribell, Inc. (2)(5)(12) | | Medical Device | | Common Stock Warrant | | | 89,903 | | | | 147 | | | | 1,205 | |
| Cognoa, Inc. (2)(12) | | Medical Device | | Common Stock Warrant | | | 61,170 | | | | — | | | | 2 | |
| Cognoa, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 7,152,669 | | | | 162 | | | | 3 | |
| Conventus Orthopaedics, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 13,203,395 | | | | 268 | | | | — | |
| CSA Medical, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 4,939,813 | | | | 174 | | | | 462 | |
| CVRx, Inc. (2)(5)(12) | | Medical Device | | Common Stock Warrant | | | 47,410 | | | | 76 | | | | 20 | |
| Infobionic, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 8,488,456 | | | | 361 | | | | 705 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Magnolia Medical Technologies, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 900,043 | | | | 194 | | | | 321 | |
| Meditrina, Inc. (12) | | Medical Device | | Preferred Stock Warrant | | | 233,993 | | | | 83 | | | | 95 | |
| Mobia Medical, Inc. fka Microtransponder, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 103,172 | | | | 47 | | | | 47 | |
| Onkos Surgical, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 443,674 | | | | 192 | | | | 200 | |
| Scientia Vascular, Inc (2)(12) | | Medical Device | | Common Stock Warrant | | | 24,000 | | | | 60 | | | | 235 | |
| Scientia Vascular, Inc (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 49,157 | | | | 206 | | | | 481 | |
| Sonex Health, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 2,637,133 | | | | 275 | | | | 199 | |
| Spineology, Inc. (2)(12) | | Medical Device | | Common Stock Warrant | | | 27,139 | | | | 65 | | | | 41 | |
| Spineology, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 45,101 | | | | 109 | | | | 69 | |
| VERO Biotech LLC (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 3,701 | | | | 379 | | | | 111 | |
| Total Non-Affiliate Warrants — Life Science | | | | | | | 5,346 | | | | 6,964 | |
| Non-Affiliate Warrants — Sustainability — 0.0% (8) | | | | | | | | | | | | | | | | |
| SparkCharge, Inc. (2)(12) | | Alternative Energy | | Preferred Stock Warrant | | | 2,264,151 | | | | 45 | | | | 36 | |
| Pivot Bio, Inc. (2)(12) | | Energy Efficiency | | Preferred Stock Warrant | | | 210,418 | | | | 14 | | | | 2 | |
| New Aerofarms, Inc. assignee of Aerofarms, Inc. (2)(12) | | Other Sustainability | | Preferred Stock Warrant | | | 800,000 | | | | 88 | | | | 30 | |
| LiquiGlide, Inc. (2)(12) | | Other Sustainability | | Preferred Stock Warrant | | | 122,717 | | | | 53 | | | | 47 | |
| Temperpack Technologies, Inc. (2)(12) | | Other Sustainability | | Preferred Stock Warrant | | | 66,605 | | | | 185 | | | | 28 | |
| Total Non-Affiliate Warrants — Sustainability | | | | | | | 385 | | | | 143 | |
| Non-Affiliate Warrants — Technology — 3.0% (8) | | | | | | | | | | | | | | | | |
| Axiom Space Holdings, Inc. (2)(12) | | Communications | | Common Stock Warrant | | | 2,654 | | | | 50 | | | | 33 | |
| Intelepeer Holdings, Inc. (2)(12) | | Communications | | Preferred Stock Warrant | | | 2,936,535 | | | | 138 | | | | 2,730 | |
| Alula Holdings, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 20,000 | | | | 93 | | | | 6 | |
| CAMP NYC, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 224,712 | | | | 57 | | | | 76 | |
| Clara Foods Co. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 46,745 | | | | 30 | | | | 41 | |
| Divergent Technologies, Inc. (2)(12) | | Consumer-related Technologies | | Common Stock Warrant | | | 13,068 | | | | 80 | | | | 59 | |
| Divergent Technologies, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 71,014 | | | | 538 | | | | 771 | |
| Havenly, Inc. (2)(12) | | Consumer-related Technologies | | Common Stock Warrant | | | 1,633,929 | | | | 3,463 | | | | 3,510 | |
| MyForest Foods Co. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 500 | | | | 41 | | | | 47 | |
| Primary Kids, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 553,778 | | | | 57 | | | | 73 | |
| Quip NYC Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 10,833 | | | | 325 | | | | — | |
| Updater, Inc.(2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 108,333 | | | | 34 | | | | — | |
| CPG Beyond, Inc. (2)(12) | | Data Storage | | Preferred Stock Warrant | | | 500,000 | | | | 242 | | | | 57 | |
| Silk, Inc. (2)(12) | | Data Storage | | Preferred Stock Warrant | | | 394,110 | | | | 175 | | | | 173 | |
| Global Worldwide LLC (2)(12) | | Internet and Media | | Preferred Stock Warrant | | | 245,810 | | | | 75 | | | | — | |
| Rocket Lawyer Incorporated (2)(12) | | Internet and Media | | Preferred Stock Warrant | | | 261,721 | | | | 92 | | | | 151 | |
| Skillshare, Inc. (2)(12) | | Internet and Media | | Preferred Stock Warrant | | | 139,316 | | | | 162 | | | | — | |
| Liqid, Inc. (2)(12) | | Networking | | Common Stock Warrant | | | 344,102 | | | | 364 | | | | — | |
| Apkudo, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 31,848 | | | | 97 | | | | 118 | |
| BriteCore Holdings, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 194,570 | | | | 137 | | | | 229 | |
| Crafty Holdings, Inc. (2)(12) | | Software | | Common Stock Warrant | | | 260,972 | | | | 138 | | | | 178 | |
| Dropoff, Inc. (2)(12) | | Software | | Common Stock Warrant | | | 723,228 | | | | 455 | | | | — | |
| HappyCo, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 96,228 | | | | 26 | | | | 20 | |
| Everstream Holdings, LLC (2)(12) | | Software | | Preferred Stock Warrant | | | 525,000 | | | | 82 | | | | — | |
| Lemongrass Holdings, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 202,616 | | | | 57 | | | | 96 | |
| Mirantis, Inc. (2)(12) | | Software | | Common Stock Warrant | | | 948,275 | | | | 223 | | | | 420 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Noodle Partners, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 84,037 | | | | 116 | | | | — | |
| OneNetworks, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 184,646 | | | | 3 | | | | 2 | |
| Revinate Holdings, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 682,034 | | | | 44 | | | | 86 | |
| SIGNiX, Inc. (12) | | Software | | Preferred Stock Warrant | | | 186,235 | | | | 177 | | | | — | |
| Slingshot Aerospace, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 309,208 | | | | 123 | | | | 45 | |
| Supply Network Visibility Holdings LLC (2)(12) | | Software | | Preferred Stock Warrant | | | 682 | | | | 64 | | | | — | |
| Topia Mobility, Inc. (2)(12) | | Software | | Common Stock Warrant | | | 30,496 | | | | 138 | | | | — | |
| Ursa Space Systems, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 1,075,072 | | | | 151 | | | | 169 | |
| Viken Detection Corporation (2)(12) | | Software | | Preferred Stock Warrant | | | 345,443 | | | | 120 | | | | 314 | |
| xAd, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 4,343,348 | | | | 177 | | | | — | |
| Total Non-Affiliate Warrants — Technology | | | | | | | 8,344 | | | | 9,404 | |
| Non-Affiliate Warrants — Healthcare information and services — 0.0% (8) | | | | | | | | | | | | | | | | |
| GT Medical Technologies, Inc. (2)(12) | | Other Healthcare | | Preferred Stock Warrant | | | 326,640 | | | | 144 | | | | 39 | |
| BrightInsight, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 232,871 | | | | 168 | | | | — | |
| Elligo Health Research, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 652,250 | | | | 191 | | | | — | |
| SafelyYou, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 206,983 | | | | 163 | | | | 98 | |
| Total Non-Affiliate Warrants — Healthcare information and services | | | | | | | 666 | | | | 137 | |
| Total Non-Affiliate Warrants | | | | | | | 14,741 | | | | 16,648 | |
| Non-Affiliate Other Investments — 0.6% (8) | | | | | | | | | | | | | | | | |
| Non-Affiliate Other Investments — Life Science — 0.6% (8) | | | | | | | | | | | | | | | | |
| BioVaxys Technology Corp. (5)(12) | | Biotechnology | | Royalty Agreement | | | | | | | 5,073 | | | | — | |
| Aerobiotix, LLC (12) | | Medical Device | | Royalty Agreement | | | | | | | 1,498 | | | | 1,574 | |
| Lumithera, Inc. (12) | | Medical Device | | Royalty Agreement | | | | | | | 1,116 | | | | 384 | |
| Robin Healthcare, Inc. (2)(12) | | Medical Device | | Royalty Agreement | | | | | | | 7,330 | | | | — | |
| Total Non-Affiliate Other Investments — Life Science | | | | | | | 15,017 | | | | 1,958 | |
| Non-Affiliate Other Investments — Technology — 0.0% (8) | | | | | | | | | | | | | | | | |
| Better Place Forests Co. (12)(16) | | Consumer-related Technologies | | Other Investment | | | | | | | 10,149 | | | | — | |
| Total Non-Affiliate Other Investments — Technology | | | | | | | 10,149 | | | | — | |
| Total Non-Affiliate Other Investments | | | | | | | 25,166 | | | | 1,958 | |
| Non-Affiliate Equity — 2.1% (8) | | | | | | | | | | | | | | | | |
| BioVaxys Technology Corp. (5)(12) | | Biotechnology | | Common Stock | | | 66,170 | | | | 14 | | | | 11 | |
| Cadrenal Therapeutics, Inc. (5) | | Biotechnology | | Common Stock | | | 40,000 | | | | — | | | | 271 | |
| Castle Creek Biosciences, Inc. (12) | | Biotechnology | | Common Stock | | | 1,162 | | | | 250 | | | | 217 | |
| Emalex Biosciences, Inc. (12) | | Biotechnology | | Preferred Stock | | | 47,461 | | | | 545 | | | | 656 | |
| Axiom Space Holdings, Inc. (12) | | Communications | | Preferred Stock | | | 1,810 | | | | 261 | | | | 306 | |
| PebblePost, Inc. (2)(12) | | Communications | | Preferred Stock | | | 56,212 | | | | 73 | | | | 73 | |
| SnagAJob.com, Inc. (12) | | Consumer-related Technologies | | Common Stock | | | 82,974 | | | | 9 | | | | — | |
| Cognoa, Inc. (2)(12) | | Medical Device | | Common Stock | | | 16,247,754 | | | | 976 | | | | 975 | |
| Cognoa, Inc. (2)(12) | | Medical Device | | Preferred Stock | | | 2,119,272 | | | | 500 | | | | 500 | |
| Tigo Energy, Inc. (5) | | Other Sustainability | | Common Stock | | | 5,205 | | | | 111 | | | | 7 | |
| Decisyon, Inc. (12) | | Software | | Preferred Stock | | | 280,000 | | | | 2,800 | | | | — | |
| Kodiak Robotics, Inc. (2)(5) | | Software | | Common Stock | | | 338,798 | | | | 3,100 | | | | 3,700 | |
| Total Non-Affiliate Equity | | | | | | | 8,639 | | | | 6,716 | |
| Total Non-Affiliate Portfolio Investment Assets | | | | | | $ | 616,236 | | | $ | 584,100 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Non-Controlled Affiliate Investments — 19.9% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Non-Controlled Affiliate Debt Investments — 11.7% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Hound Labs II, LLC (12) | | Diagnostics | | Term Loan | | | 12.75 | % (11) | Prime | | | 6.00 | % | | | 9.25 | % | | | — | | | | — | | July 1, 2027 | | $ | 6,789 | | | $ | 6,789 | | | $ | 6,605 | |
| NextCar Holding Company, Inc. (12)(14) | | Consumer-related Technologies | | Term Loan | | | 10.00 | % | Fixed | | | 0.00 | % | | | 0.00 | % | | | — | | | | — | | March 31, 2026 | | | 2,266 | | | | 2,266 | | | | 1,079 | |
| Nexii, Inc. (12) | | Other Sustainability | | Term Loan | | | 10.00 | % | Fixed | | | 0.00 | % | | | 0.00 | % | | | — | | | | — | | July 1, 2027 | | | 790 | | | | 826 | | | | — | |
| | | | | Term Loan (17) | | | 10.00 | % | Fixed | | | 0.00 | % | | | 0.00 | % | | | — | | | | — | | July 1, 2027 | | | 304 | | | | 172 | | | | — | |
| Shengrow, Inc. aka Soli Organic, Inc. (2)(12) | | Other Sustainability | | Term Loan (17) | | | 11.75 | % (11) | Prime | | | 4.50 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 5,246 | | | | 428 | | | | 5,246 | |
| | | | | Term Loan | | | 11.75 | % (11) | Prime | | | 4.50 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 3,497 | | | | 3,447 | | | | 3,447 | |
| | | | | Term Loan | | | 11.75 | % (11) | Prime | | | 4.50 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 1,749 | | | | 1,724 | | | | 1,724 | |
| | | | | Term Loan | | | 11.75 | % (11) | Prime | | | 4.50 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 3,497 | | | | 3,447 | | | | 3,447 | |
| | | | | Term Loan | | | 11.75 | % (11) | Prime | | | 4.50 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 1,749 | | | | 1,723 | | | | 1,723 | |
| | | | | Term Loan | | | 11.75 | % (11) | Prime | | | 4.50 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 3,497 | | | | 3,445 | | | | 3,445 | |
| | | | | Term Loan | | | 11.75 | % (11) | Prime | | | 4.50 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 1,749 | | | | 1,722 | | | | 1,722 | |
| | | | | Revolver | | | 11.75 | % | Prime | | | 5.00 | % | | | 9.75 | % | | | — | | | | — | | November 26, 2026 | | | 5,000 | | | | 5,000 | | | | 5,000 | |
| | | | | Revolver | | | 11.75 | % | Prime | | | 5.00 | % | | | 9.75 | % | | | — | | | | — | | November 26, 2026 | | | 5,000 | | | | 3,809 | | | | 3,809 | |
| Total Non-Controlled Affiliate Investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 34,798 | | | | 37,247 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Non-Controlled Affiliate Other Investments — 0.5% (8) | | | | | | | | | | | | | | | | |
| Evelo Holdings, Inc. (2)(5)(12)(15) | | Biotechnology | | Other Investment | | | | | | $ | 20,092 | | | $ | 1,486 | |
| Total Non-Controlled Affiliate Other Investments | | | | | | | 20,092 | | | | 1,486 | |
| Non-controlled Affiliate Equity — 7.7% (8) | | | | | | | | | | | | | | | | |
| Aulea Medical, Inc. (12) | | Medical Device | | Common Stock | | | 660,537 | | | | — | | | | — | |
| Evelo Holdings, Inc. (2)(5)(12) | | Biotechnology | | Common Stock | | | 2,164,502 | | | | 5,000 | | | | — | |
| Hound Labs II, LLC (12) | | Diagnostics | | Preferred Stock | | | 4,769 | | | | 4,764 | | | | 4,764 | |
| NextCar Holding Company, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock | | | 2,688,971 | | | | — | | | | — | |
| Nexii, Inc. (2)(12) | | Other Sustainability | | Preferred Stock | | | 168,377 | | | | 9,751 | | | | — | |
| Shengrow, Inc. aka Soli Organic, Inc. (2)(12) | | Other Sustainability | | Common Stock | | | 4,274,555 | | | | 1,292 | | | | 1,292 | |
| Shengrow, Inc. aka Soli Organic, Inc. (2)(12) | | Other Sustainability | | Preferred Stock | | | 1,964,733 | | | | 13,209 | | | | 18,355 | |
| Total Non-Controlled Affiliate Equity | | | | | | | 34,016 | | | | 24,411 | |
| Non-controlled Affiliate Warrants — 0.0% (8) | | | | | | | | | | | | | | | | |
| Evelo Holdings, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 23,196 | | | | 127 | | | | — | |
| Total Non-Controlled Affiliate Warrants | | | | | | | 127 | | | | — | |
| Total Non-Controlled Affiliate Portfolio Investment Assets | | | | | | $ | 89,033 | | | $ | 63,144 | |
| Total Portfolio Investment Assets — 203.2% (8) | | | | | | $ | 705,269 | | | $ | 647,244 | |
| Short Term Investments - Unrestricted Investments - 10.9% (8) | | | | | | | | |
| US Bank Money Market Deposit Account | | | 34,711 | | | | 34,711 | |
| Total Short Term Investments - Unrestricted Investments | | $ | 34,711 | | | $ | 34,711 | |
| | | | | | | | | |
| Short Term Investments - Restricted Investments - 0.8% (8) | | | | | | | | |
| US Bank Money Market Deposit Account | | | 2,463 | | | | 2,463 | |
| Total Short Term Investments - Restricted Investments | | $ | 2,463 | | | $ | 2,463 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Non-Affiliate Investments — 195.6% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Non-Affiliate Debt Investments — 187.7% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Non-Affiliate Debt Investments — Life Science — 77.8% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Castle Creek Biosciences, Inc. (2)(12) | | Biotechnology | | Term Loan | | | 12.88 | % | Prime | | | 5.13 | % | | | 9.55 | % | | | 13.50 | % | | | 5.50 | % | | May 1, 2026 | | $ | 3,333 | | | $ | 3,326 | | | $ | 3,326 | |
| | | | | Term Loan | | | 12.88 | % | Prime | | | 5.13 | % | | | 9.55 | % | | | 13.50 | % | | | 5.50 | % | | May 1, 2026 | | | 3,333 | | | | 3,326 | | | | 3,326 | |
| | | | | Term Loan | | | 12.88 | % | Prime | | | 5.13 | % | | | 9.55 | % | | | 13.50 | % | | | 5.50 | % | | May 1, 2026 | | | 2,000 | | | | 1,996 | | | | 1,996 | |
| | | | | Term Loan | | | 12.88 | % | Prime | | | 5.13 | % | | | 9.55 | % | | | 13.50 | % | | | 5.50 | % | | May 1, 2026 | | | 3,333 | | | | 3,326 | | | | 3,326 | |
| | | | | Term Loan | | | 12.88 | % | Prime | | | 5.13 | % | | | 9.55 | % | | | 13.50 | % | | | 5.50 | % | | May 1, 2026 | | | 3,333 | | | | 3,326 | | | | 3,326 | |
| | | | | Term Loan | | | 12.88 | % | Prime | | | 5.13 | % | | | 9.55 | % | | | 13.50 | % | | | 5.50 | % | | May 1, 2026 | | | 2,000 | | | | 1,996 | | | | 1,996 | |
| Emalex Biosciences, Inc. (2)(12) | | Biotechnology | | Term Loan | | | 12.22 | % | Prime | | | 4.72 | % | | | 9.75 | % | | | — | | | | 5.00 | % | | November 1, 2025 | | | 4,167 | | | | 4,144 | | | | 4,144 | |
| | | | | Term Loan | | | 12.22 | % | Prime | | | 4.72 | % | | | 9.75 | % | | | — | | | | 5.00 | % | | May 1, 2026 | | | 5,000 | | | | 4,982 | | | | 4,982 | |
| Greenlight Biosciences, Inc. (2)(12) | | Biotechnology | | Term Loan | | | 13.25 | % | Prime | | | 5.75 | % | | | 9.00 | % | | | — | | | | 3.00 | % | | July 1, 2025 | | | 1,000 | | | | 971 | | | | 971 | |
| | | | | Term Loan | | | 13.25 | % | Prime | | | 5.75 | % | | | 9.00 | % | | | — | | | | 3.00 | % | | July 1, 2025 | | | 500 | | | | 486 | | | | 486 | |
| KSQ Therapeutics, Inc. (2)(12) | | Biotechnology | | Term Loan | | | 12.25 | % | Prime | | | 4.75 | % | | | 8.50 | % | | | — | | | | 5.50 | % | | May 1, 2027 | | | 6,250 | | | | 6,220 | | | | 6,220 | |
| | | | | Term Loan | | | 12.25 | % | Prime | | | 4.75 | % | | | 8.50 | % | | | — | | | | 5.50 | % | | May 1, 2027 | | | 6,250 | | | | 6,220 | | | | 6,220 | |
| Native Microbials, Inc (2)(12) | | Biotechnology | | Term Loan | | | 12.75 | % | Prime | | | 5.25 | % | | | 8.50 | % | | | — | | | | 5.00 | % | | November 1, 2026 | | | 2,875 | | | | 2,862 | | | | 2,862 | |
| | | | | Term Loan | | | 12.75 | % | Prime | | | 5.25 | % | | | 8.50 | % | | | — | | | | 5.00 | % | | November 1, 2026 | | | 1,917 | | | | 1,906 | | | | 1,906 | |
| PDS Biotechnology Corporation (2)(5)(12) | | Biotechnology | | Term Loan | | | 13.25 | % | Prime | | | 5.75 | % | | | 9.75 | % | | | — | | | | 3.75 | % | | September 1, 2026 | | | 8,750 | | | | 8,712 | | | | 8,712 | |
| | | | | Term Loan | | | 13.25 | % | Prime | | | 5.75 | % | | | 9.75 | % | | | — | | | | 3.75 | % | | September 1, 2026 | | | 3,281 | | | | 3,267 | | | | 3,267 | |
| | | | | Term Loan | | | 13.25 | % | Prime | | | 5.75 | % | | | 9.75 | % | | | — | | | | 3.75 | % | | September 1, 2026 | | | 3,281 | | | | 3,267 | | | | 3,267 | |
| Provivi, Inc. (2)(12) | | Biotechnology | | Term Loan | | | 12.86 | % | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.30 | % | | January 1, 2027 | | | 3,482 | | | | 3,418 | | | | 3,182 | |
| | | | | Term Loan | | | 12.86 | % | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.30 | % | | January 1, 2027 | | | 3,482 | | | | 3,418 | | | | 3,182 | |
| | | | | Term Loan | | | 12.86 | % | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.31 | % | | January 1, 2027 | | | 1,741 | | | | 1,705 | | | | 1,588 | |
| | | | | Term Loan | | | 12.86 | % | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.31 | % | | January 1, 2027 | | | 1,741 | | | | 1,705 | | | | 1,588 | |
| | | | | Term Loan | | | 12.86 | % | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.31 | % | | January 1, 2027 | | | 1,741 | | | | 1,704 | | | | 1,587 | |
| | | | | Term Loan | | | 12.86 | % | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.31 | % | | January 1, 2027 | | | 1,741 | | | | 1,704 | | | | 1,587 | |
| Stealth Biotherapeutics Inc. (2)(12) | | Biotechnology | | Term Loan | | | 13.00 | % | Prime | | | 5.50 | % | | | 8.75 | % | | | — | | | | 6.00 | % | | October 1, 2025 | | | 2,024 | | | | 1,999 | | | | 1,999 | |
| | | | | Term Loan | | | 13.00 | % | Prime | | | 5.50 | % | | | 8.75 | % | | | — | | | | 6.00 | % | | October 1, 2025 | | | 1,012 | | | | 1,000 | | | | 1,000 | |
| Tallac Therapeutics, Inc. (2)(12) | | Biotechnology | | Term Loan | | | 12.25 | % | Prime | | | 4.25 | % | | | 12.25 | % | | | — | | | | 4.00 | % | | August 1, 2027 | | | 2,500 | | | | 2,471 | | | | 2,471 | |
| | | | | Term Loan | | | 12.25 | % | Prime | | | 4.25 | % | | | 12.25 | % | | | — | | | | 4.00 | % | | August 1, 2027 | | | 2,500 | | | | 2,471 | | | | 2,471 | |
| Aerobiotix, LLC (2)(12) | | Medical Device | | Term Loan | | | 9.00 | % | Fixed | | | — | | | | — | | | | — | | | | 18.00 | % | | April 1, 2028 | | | 2,500 | | | | 2,480 | | | | 2,085 | |
| | | | | Term Loan | | | 9.00 | % | Fixed | | | — | | | | — | | | | — | | | | 18.00 | % | | April 1, 2028 | | | 2,500 | | | | 2,480 | | | | 2,085 | |
| | | | | Term Loan | | | 9.00 | % | Fixed | | | — | | | | — | | | | — | | | | 18.00 | % | | April 1, 2028 | | | 200 | | | | 190 | | | | 160 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Candesant Biomedical, Inc. (2)(12) | | Medical Device | | Term Loan | | | 11.50 | % | Prime | | | 3.50 | % | | | 11.50 | % | | | — | | | | 5.00 | % | | September 1, 2027 | | | 5,000 | | | | 4,785 | | | | 4,785 | |
| | | | | Term Loan | | | 11.50 | % | Prime | | | 3.50 | % | | | 11.50 | % | | | — | | | | 5.00 | % | | September 1, 2027 | | | 2,500 | | | | 2,468 | | | | 2,468 | |
| | | | | Term Loan | | | 11.50 | % | Prime | | | 3.50 | % | | | 11.50 | % | | | — | | | | 5.00 | % | | September 1, 2027 | | | 2,500 | | | | 2,468 | | | | 2,468 | |
| Ceribell, Inc. (2)(5)(12) | | Medical Device | | Term Loan | | | 10.25 | % | Prime | | | 2.75 | % | | | 9.25 | % | | | — | | | | 4.00 | % | | March 1, 2029 | | | 5,000 | | | | 4,820 | | | | 4,820 | |
| | | | | Term Loan | | | 10.25 | % | Prime | | | 2.75 | % | | | 9.25 | % | | | — | | | | 4.00 | % | | March 1, 2029 | | | 5,000 | | | | 4,941 | | | | 4,941 | |
| | | | | Term Loan | | | 10.25 | % | Prime | | | 2.75 | % | | | 9.25 | % | | | — | | | | 4.00 | % | | March 1, 2029 | | | 4,000 | | | | 3,952 | | | | 3,952 | |
| Conventus Orthopaedics, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.32 | % | Prime | | | 4.82 | % | | | 9.25 | % | | | — | | | | 10.36 | % | | July 1, 2025 | | | 3,187 | | | | 3,168 | | | | 3,168 | |
| | | | | Term Loan | | | 12.32 | % | Prime | | | 4.82 | % | | | 9.25 | % | | | — | | | | 10.36 | % | | July 1, 2025 | | | 3,187 | | | | 3,168 | | | | 3,168 | |
| Infobionic, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.25 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 2.00 | % | | September 1, 2029 | | | 5,000 | | | | 4,920 | | | | 4,920 | |
| | | | | Term Loan | | | 12.25 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 2.00 | % | | September 1, 2029 | | | 5,000 | | | | 4,920 | | | | 4,920 | |
| | | | | Term Loan | | | 12.25 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 2.00 | % | | September 1, 2029 | | | 5,000 | | | | 4,920 | | | | 4,920 | |
| Mobia Medical, Inc. fka Microtransponder, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 3.50 | % | | January 1, 2029 | | | 3,750 | | | | 3,699 | | | | 3,699 | |
| | | | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 3.50 | % | | January 1, 2029 | | | 3,750 | | | | 3,699 | | | | 3,699 | |
| Onkos Surgical, Inc. (2)(12) | | Medical Device | | Term Loan | | | 10.75 | % | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | | January 1, 2030 | | | 10,000 | | | | 9,818 | | | | 9,818 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | | January 1, 2030 | | | 10,000 | | | | 9,845 | | | | 9,845 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | | January 1, 2030 | | | 5,000 | | | | 4,923 | | | | 4,923 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | | January 1, 2030 | | | 5,000 | | | | 4,923 | | | | 4,923 | |
| Scientia Vascular, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.50 | % | Prime | | | 4.75 | % | | | 8.50 | % | | | — | | | | 5.00 | % | | January 1, 2027 | | | 3,750 | | | | 3,735 | | | | 3,735 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 4.75 | % | | | 8.50 | % | | | — | | | | 5.00 | % | | January 1, 2027 | | | 3,750 | | | | 3,735 | | | | 3,735 | |
| | | | | Term Loan | | | 13.00 | % | Prime | | | 5.25 | % | | | 9.00 | % | | | — | | | | 5.00 | % | | January 1, 2027 | | | 5,000 | | | | 4,964 | | | | 4,964 | |
| | | | | Term Loan | | | 13.00 | % | Prime | | | 5.25 | % | | | 9.00 | % | | | — | | | | 5.00 | % | | January 1, 2027 | | | 5,000 | | | | 4,937 | | | | 4,937 | |
| Sonex Health, Inc. (2)(12) | | Medical Device | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | | September 1, 2027 | | | 2,500 | | | | 2,480 | | | | 2,480 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | | September 1, 2027 | | | 2,500 | | | | 2,480 | | | | 2,480 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | | September 1, 2027 | | | 5,000 | | | | 4,961 | | | | 4,961 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | | September 1, 2027 | | | 5,000 | | | | 4,961 | | | | 4,961 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | | April 1, 2028 | | | 3,750 | | | | 3,714 | | | | 3,714 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | | April 1, 2028 | | | 3,750 | | | | 3,714 | | | | 3,714 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | | April 1, 2028 | | | 3,750 | | | | 3,714 | | | | 3,714 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | | April 1, 2028 | | | 3,750 | | | | 3,714 | | | | 3,714 | |
| Spineology, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.50 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 1.00 | % | | August 1, 2029 | | | 5,000 | | | | 4,916 | | | | 4,916 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 1.00 | % | | August 1, 2029 | | | 4,250 | | | | 4,178 | | | | 4,178 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 1.00 | % | | August 1, 2029 | | | 4,250 | | | | 4,178 | | | | 4,178 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 1.00 | % | | August 1, 2029 | | | 2,500 | | | | 2,458 | | | | 2,458 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Vero Biotech, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 4.00 | % | | January 1, 2029 | | | 15,000 | | | | 14,735 | | | | 14,735 | |
| | | | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 4.00 | % | | January 1, 2029 | | | 10,000 | | | | 9,823 | | | | 9,823 | |
| | | | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 4.00 | % | | January 1, 2029 | | | 5,000 | | | | 4,912 | | | | 4,912 | |
| | | | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 4.00 | % | | January 1, 2029 | | | 2,500 | | | | 2,456 | | | | 2,456 | |
| Total Non-Affiliate Debt Investments — Life Science | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 263,280 | | | | 261,520 | |
| Non-Affiliate Debt Investments — Sustainability — 19.9% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Pivot Bio, Inc.(2)(12) | | Energy Efficiency | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 4.00 | % | | February 1, 2029 | | | 5,000 | | | | 4,742 | | | | 4,742 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 4.00 | % | | February 1, 2029 | | | 5,000 | | | | 4,951 | | | | 4,951 | |
| New Aerofarms, Inc. assignee of Aerofarms, Inc. (2)(12)(14) | | Other Sustainability | | Term Loan | | | 14.25 | % | Prime | | | 6.75 | % | | | 10.00 | % | | | — | | | | 4.33 | % | | December 1, 2026 | | | 3,594 | | | | 3,564 | | | | 3,564 | |
| | | | | Term Loan | | | 14.25 | % | Prime | | | 6.75 | % | | | 10.00 | % | | | — | | | | 4.33 | % | | December 1, 2026 | | | 3,594 | | | | 3,564 | | | | 3,564 | |
| Soli Organic, Inc. (2)(12) | | Other Sustainability | | Term Loan | | | 14.25 | % | Prime | | | 6.75 | % | | | 10.00 | % | | | — | | | | 2.75 | % | | April 1, 2026 | | | 5,000 | | | | 4,922 | | | | 4,792 | |
| | | | | Term Loan | | | 14.25 | % | Prime | | | 6.75 | % | | | 10.00 | % | | | — | | | | 2.75 | % | | April 1, 2026 | | | 2,500 | | | | 2,461 | | | | 2,396 | |
| | | | | Term Loan | | | 14.25 | % | Prime | | | 6.75 | % | | | 10.00 | % | | | — | | | | 2.75 | % | | May 1, 2026 | | | 5,000 | | | | 4,922 | | | | 4,792 | |
| | | | | Term Loan | | | 14.25 | % | Prime | | | 6.75 | % | | | 10.00 | % | | | — | | | | 2.75 | % | | May 1, 2026 | | | 2,500 | | | | 2,461 | | | | 2,396 | |
| | | | | Term Loan | | | 13.00 | % | Prime | | | 5.50 | % | | | 11.75 | % | | | — | | | | 2.75 | % | | December 1, 2026 | | | 5,000 | | | | 4,925 | | | | 4,795 | |
| | | | | Term Loan | | | 13.00 | % | Prime | | | 5.50 | % | | | 11.75 | % | | | — | | | | 2.75 | % | | December 1, 2026 | | | 2,500 | | | | 2,462 | | | | 2,397 | |
| Temperpack Technologies, Inc. (2)(12) | | Other Sustainability | | Term Loan | | | 14.25 | % | Prime | | | 6.75 | % | | | 10.00 | % | | | — | | | | 2.50 | % | | April 1, 2028 | | | 3,750 | | | | 3,707 | | | | 3,707 | |
| | | | | Term Loan | | | 14.25 | % | Prime | | | 6.75 | % | | | 10.00 | % | | | — | | | | 2.50 | % | | April 1, 2028 | | | 3,750 | | | | 3,707 | | | | 3,707 | |
| | | | | Term Loan | | | 14.25 | % | Prime | | | 6.75 | % | | | 10.00 | % | | | — | | | | 2.50 | % | | April 1, 2028 | | | 7,500 | | | | 7,407 | | | | 7,407 | |
| | | | | Term Loan | | | 14.25 | % | Prime | | | 6.75 | % | | | 10.00 | % | | | — | | | | 2.50 | % | | April 1, 2028 | | | 3,750 | | | | 3,704 | | | | 3,704 | |
| | | | | Term Loan | | | 14.25 | % | Prime | | | 6.75 | % | | | 10.00 | % | | | — | | | | 2.50 | % | | April 1, 2028 | | | 3,750 | | | | 3,704 | | | | 3,704 | |
| | | | | Term Loan | | | 13.50 | % | Prime | | | 6.00 | % | | | 10.00 | % | | | — | | | | 2.00 | % | | January 1, 2029 | | | 4,500 | | | | 4,454 | | | | 4,454 | |
| | | | | Term Loan | | | 13.50 | % | Prime | | | 6.00 | % | | | 10.00 | % | | | — | | | | 2.00 | % | | January 1, 2029 | | | 2,000 | | | | 1,980 | | | | 1,980 | |
| Total Non-Affiliate Debt Investments — Sustainability | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 67,637 | | | | 67,052 | |
| Non-Affiliate Debt Investments — Technology — 59.0% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Axiom Space, Inc. (2)(12) | | Communications | | Term Loan | | | 13.75 | % | Prime | | | 6.00 | % | | | 9.25 | % | | | — | | | | 2.50 | % | | June 1, 2026 | | | 3,750 | | | | 3,731 | | | | 3,731 | |
| | | | | Term Loan | | | 13.75 | % | Prime | | | 6.00 | % | | | 9.25 | % | | | — | | | | 2.50 | % | | June 1, 2026 | | | 3,750 | | | | 3,731 | | | | 3,731 | |
| | | | | Term Loan | | | 13.75 | % | Prime | | | 6.00 | % | | | 9.25 | % | | | — | | | | 2.50 | % | | June 1, 2026 | | | 3,750 | | | | 3,731 | | | | 3,731 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Havenly, Inc. (2)(12) | | Consumer-related Technologies | | Term Loan | | | 12.50 | % | Prime | | | 5.00 | % | | | 5.00 | % | | | — | | | | 10.40 | % | | March 1, 2027 | | | 2,000 | | | | 1,568 | | | | 1,568 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.00 | % | | | 5.00 | % | | | — | | | | 10.40 | % | | March 1, 2027 | | | 3,000 | | | | 2,529 | | | | 2,529 | |
| | | | | Term Loan | | | 11.00 | % | Prime | | | 3.50 | % | | | 10.50 | % | | | — | | | | 7.78 | % | | February 1, 2028 | | | 2,813 | | | | 2,813 | | | | 2,813 | |
| | | | | Term Loan | | | 11.00 | % | Prime | | | 3.50 | % | | | 10.50 | % | | | — | | | | 7.78 | % | | February 1, 2028 | | | 2,813 | | | | 2,813 | | | | 2,813 | |
| Lyrical Foods, Inc. (2)(12) | | Consumer-related Technologies | | Term Loan | | | 11.00% | (11) | Prime | | | 3.50 | % | | | 9.00 | % | | | — | | | | 5.00 | % | | July 1, 2028 | | | 2,679 | | | | 2,768 | | | | 2,405 | |
| NextCar Holding Company, Inc. (2)(12)(13) | | Consumer-related Technologies | | Term Loan | | | 13.50% | (11) | Prime | | | 5.75 | % | | | 9.00 | % | | | — | | | | 5.25 | % | | October 31, 2023 | | | 6,042 | | | | 5,415 | | | | 1,271 | |
| | | | | Term Loan | | | 13.50% | (11) | Prime | | | 5.75 | % | | | 9.00 | % | | | — | | | | 5.25 | % | | October 31, 2023 | | | 3,021 | | | | 2,707 | | | | 635 | |
| | | | | Term Loan | | | 13.50% | (11) | Prime | | | 5.75 | % | | | 9.00 | % | | | — | | | | 5.25 | % | | October 31, 2023 | | | 2,417 | | | | 2,166 | | | | 508 | |
| | | | | Term Loan | | | 13.50% | (11) | Prime | | | 5.75 | % | | | 9.00 | % | | | — | | | | 5.25 | % | | October 31, 2023 | | | 3,021 | | | | 2,707 | | | | 635 | |
| | | | | Term Loan | | | 13.50% | (11) | Prime | | | 5.75 | % | | | 9.00 | % | | | — | | | | 5.25 | % | | October 31, 2023 | | | 3,625 | | | | 3,249 | | | | 762 | |
| | | | | Term Loan | | | 13.50% | (11) | Prime | | | 5.75 | % | | | 9.00 | % | | | — | | | | 5.25 | % | | October 31, 2023 | | | 3,021 | | | | 2,707 | | | | 635 | |
| | | | | Term Loan | | | 13.50% | (11) | Prime | | | 5.75 | % | | | 9.00 | % | | | — | | | | 5.25 | % | | October 31, 2023 | | | 6,042 | | | | 5,415 | | | | 1,271 | |
| | | | | Term Loan | | | 13.50% | (11) | Prime | | | 5.75 | % | | | 9.00 | % | | | — | | | | 5.25 | % | | October 31, 2023 | | | 3,021 | | | | 2,707 | | | | 635 | |
| Optoro, Inc. (2)(12) | | Consumer-related Technologies | | Term Loan | | | 14.00 | % | Prime | | | 6.25 | % | | | 9.50 | % | | | — | | | | 4.00 | % | | August 1, 2027 | | | 2,500 | | | | 2,448 | | | | 2,448 | |
| | | | | Term Loan | | | 14.00 | % | Prime | | | 6.25 | % | | | 9.50 | % | | | — | | | | 4.00 | % | | July 1, 2028 | | | 1,875 | | | | 1,805 | | | | 1,805 | |
| Standvast Holdings, LLC (2)(12) | | Consumer-related Technologies | | Term Loan | | | 12.75 | % | Prime | | | 4.25 | % | | | 12.75 | % | | | — | | | | 3.00 | % | | June 1, 2028 | | | 2,500 | | | | 2,339 | | | | 2,267 | |
| | | | | Term Loan | | | 12.75 | % | Prime | | | 4.25 | % | | | 12.75 | % | | | — | | | | 3.00 | % | | June 1, 2028 | | | 2,500 | | | | 2,426 | | | | 2,352 | |
| | | | | Term Loan | | | 12.75 | % | Prime | | | 4.25 | % | | | 12.75 | % | | | — | | | | 3.00 | % | | November 1, 2028 | | | 2,500 | | | | 2,417 | | | | 2,343 | |
| Unagi, Inc. (2)(12)(13) | | Consumer-related Technologies | | Term Loan | | | 15.25% | (11) | Prime | | | 7.75 | % | | | 11.00 | % | | | — | | | | — | | | May 1, 2027 | | | 1,415 | | | | 1,086 | | | | — | |
| | | | | Term Loan | | | 15.25% | (11) | Prime | | | 7.75 | % | | | 11.00 | % | | | — | | | | — | | | May 1, 2027 | | | 708 | | | | 543 | | | | — | |
| | | | | Term Loan | | | 15.25% | (11) | Prime | | | 7.75 | % | | | 11.00 | % | | | — | | | | — | | | May 1, 2027 | | | 708 | | | | 543 | | | | — | |
| Fictiv, Inc. (2)(12) | | Networking | | Term Loan | | | 10.88 | % | Prime | | | 3.375 | % | | | 10.00 | % | | | — | | | | 4.00 | % | | April 1, 2029 | | | 5,000 | | | | 4,706 | | | | 4,706 | |
| | | | | Term Loan | | | 10.88 | % | Prime | | | 3.375 | % | | | 10.00 | % | | | — | | | | 4.00 | % | | April 1, 2029 | | | 5,000 | | | | 4,941 | | | | 4,941 | |
| BriteCore Holdings, Inc. (2)(12) | | Software | | Term Loan | | | 14.00 | % | Prime | | | 5.50 | % | | | 14.00 | % | | | — | | | | 3.00 | % | | October 1, 2028 | | | 5,000 | | | | 4,909 | | | | 4,909 | |
| | | | | Term Loan | | | 14.00 | % | Prime | | | 5.50 | % | | | 14.00 | % | | | — | | | | 3.00 | % | | October 1, 2028 | | | 2,500 | | | | 2,472 | | | | 2,472 | |
| | | | | Term Loan | | | 14.00 | % | Prime | | | 5.50 | % | | | 14.00 | % | | | — | | | | 3.00 | % | | October 1, 2028 | | | 2,500 | | | | 2,472 | | | | 2,472 | |
| | | | | Term Loan | | | 14.00 | % | Prime | | | 5.50 | % | | | 14.00 | % | | | — | | | | 3.00 | % | | October 1, 2028 | | | 2,500 | | | | 2,472 | | | | 2,472 | |
| | | | | Term Loan | | | 14.00 | % | Prime | | | 5.50 | % | | | 14.00 | % | | | — | | | | 3.00 | % | | April 1, 2029 | | | 2,500 | | | | 2,469 | | | | 2,469 | |
| Crafty Holdings, Inc. (2)(12) | | Software | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 4.00 | % | | January 1, 2029 | | | 5,000 | | | | 4,846 | | | | 4,846 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 4.00 | % | | January 1, 2029 | | | 5,000 | | | | 4,911 | | | | 4,911 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 4.00 | % | | January 1, 2029 | | | 5,000 | | | | 4,911 | | | | 4,911 | |
| OneNetworks, Inc. (2)(12) | | Software | | Term Loan | | | 11.125 | % | Prime | | | 3.625 | % | | | 11.00 | % | | | — | | | | 3.75 | % | | January 1, 2030 | | | 2,500 | | | | 2,448 | | | | 2,448 | |
| | | | | Term Loan | | | 11.125 | % | Prime | | | 3.625 | % | | | 11.00 | % | | | — | | | | 3.75 | % | | January 1, 2030 | | | 2,500 | | | | 2,474 | | | | 2,474 | |
| Dropoff, Inc. (2)(12) | | Software | | Term Loan | | | 14.00 | % | Prime | | | 6.50 | % | | | 9.75 | % | | | — | | | | 3.50 | % | | June 1, 2026 | | | 6,804 | | | | 6,740 | | | | 6,362 | |
| | | | | Term Loan | | | 14.00 | % | Prime | | | 6.50 | % | | | 9.75 | % | | | — | | | | 3.50 | % | | June 1, 2026 | | | 6,280 | | | | 6,221 | | | | 5,872 | |
| | | | | Term Loan | | | 14.00 | % | Prime | | | 6.50 | % | | | 9.75 | % | | | — | | | | 3.50 | % | | June 1, 2026 | | | 2,617 | | | | 2,595 | | | | 2,449 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Kodiak Robotics, Inc. (2)(12) | | Software | | Term Loan | | | 13.00 | % | Prime | | | 5.50 | % | | | 10.25 | % | | | — | | | | 4.00 | % | April 1, 2026 | | | 10,000 | | | | 9,977 | | | | 9,977 | |
| | | | | Term Loan | | | 13.00 | % | Prime | | | 5.50 | % | | | 10.25 | % | | | — | | | | 4.00 | % | April 1, 2026 | | | 10,000 | | | | 9,955 | | | | 9,955 | |
| | | | | Term Loan | | | 13.00 | % | Prime | | | 5.50 | % | | | 10.25 | % | | | — | | | | 4.00 | % | April 1, 2026 | | | 5,000 | | | | 4,978 | | | | 4,978 | |
| | | | | Term Loan | | | 13.00 | % | Prime | | | 5.50 | % | | | 10.25 | % | | | — | | | | 4.00 | % | April 1, 2026 | | | 5,000 | | | | 4,978 | | | | 4,978 | |
| Mirantis, Inc. (2)(12) | | Software | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2028 | | | 5,000 | | | | 4,934 | | | | 4,934 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2028 | | | 5,000 | | | | 4,934 | | | | 4,934 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2028 | | | 5,000 | | | | 4,934 | | | | 4,934 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2028 | | | 5,000 | | | | 4,934 | | | | 4,934 | |
| Noodle Partners, Inc. (2)(12) | | Software | | Term Loan | | | 12.50 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | March 1, 2027 | | | 10,000 | | | | 9,928 | | | | 9,928 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | March 1, 2027 | | | 5,000 | | | | 4,964 | | | | 4,964 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | March 1, 2027 | | | 5,000 | | | | 4,964 | | | | 4,964 | |
| Supply Network Visibility Holdings LLC (2)(12) | | Software | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | June 1, 2028 | | | 2,500 | | | | 2,414 | | | | 2,414 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | June 1, 2028 | | | 3,500 | | | | 3,492 | | | | 3,492 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | June 1, 2028 | | | 2,500 | | | | 2,494 | | | | 2,494 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | June 1, 2028 | | | 1,500 | | | | 1,496 | | | | 1,496 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | July 1, 2029 | | | 5,000 | | | | 4,984 | | | | 4,984 | |
| Ursa Space Systems, Inc. (2)(12) | | Software | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | November 1, 2028 | | | 2,500 | | | | 2,365 | | | | 2,365 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | November 1, 2028 | | | 2,500 | | | | 2,440 | | | | 2,440 | |
| Viken Detection Corporation (2)(12) | | Software | | Term Loan | | | 11.75 | % | Prime | | | 4.00 | % | | | 11.75 | % | | | — | | | | 3.50 | % | June 1, 2027 | | | 4,833 | | | | 4,791 | | | | 4,791 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 4.00 | % | | | 11.75 | % | | | — | | | | 3.50 | % | June 1, 2027 | | | 2,417 | | | | 2,396 | | | | 2,396 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 4.00 | % | | | 11.75 | % | | | — | | | | 3.50 | % | June 1, 2027 | | | 2,417 | | | | 2,396 | | | | 2,396 | |
| Total Non-Affiliate Debt Investments — Technology | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 222,699 | | | | 198,350 | |
| Non-Affiliate Debt Investments — Healthcare information and services — 31.0% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Hound Labs Inc. (12)(13) | | Diagnostics | | Term Loan | | | 13.50 | % | Prime | | | 6.00 | % | | | 9.25 | % | | | — | | | | 3.50 | % | June 1, 2026 | | | 1,607 | | | | 1,576 | | | | 943 | |
| | | | | Term Loan | | | 13.50 | % | Prime | | | 6.00 | % | | | 9.25 | % | | | — | | | | 3.50 | % | June 1, 2026 | | | 1,607 | | | | 1,576 | | | | 943 | |
| | | | | Term Loan | | | 13.50 | % | Prime | | | 6.00 | % | | | 9.25 | % | | | — | | | | 3.50 | % | June 1, 2026 | | | 3,214 | | | | 3,151 | | | | 1,886 | |
| | | | | Term Loan | | | 14.00 | % | Fixed | | | — | | | | — | | | | — | | | | 50.00 | % | March 1, 2025 | | | 300 | | | | 300 | | | | 180 | |
| | | | | Term Loan | | | 14.00 | % | Fixed | | | — | | | | — | | | | — | | | | 100.00 | % | March 1, 2025 | | | 250 | | | | 250 | | | | 150 | |
| Parse Biosciences, Inc. (2)(12) | | Diagnostics | | Term Loan | | | 11.50 | % | Prime | | | 3.25 | % | | | 11.50 | % | | | — | | | | 5.00 | % | January 1, 2028 | | | 5,000 | | | | 4,659 | | | | 4,659 | |
| | | | | Term Loan | | | 11.50 | % | Prime | | | 3.25 | % | | | 11.50 | % | | | — | | | | 5.00 | % | January 1, 2028 | | | 5,000 | | | | 4,910 | | | | 4,910 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| BrightInsight, Inc. (2)(12) | | Software | | Term Loan | | | 13.25 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 3.00 | % | August 1, 2027 | | | 7,000 | | | | 6,954 | | | | 6,954 | |
| | | | | Term Loan | | | 13.25 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 3.00 | % | August 1, 2027 | | | 3,500 | | | | 3,477 | | | | 3,477 | |
| | | | | Term Loan | | | 13.25 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 3.00 | % | August 1, 2027 | | | 3,500 | | | | 3,477 | | | | 3,477 | |
| | | | | Term Loan | | | 13.25 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 3.00 | % | April 1, 2028 | | | 2,750 | | | | 2,719 | | | | 2,719 | |
| Elligo Health Research, Inc. (2)(12) | | Software | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2027 | | | 10,000 | | | | 9,890 | | | | 9,890 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2027 | | | 5,000 | | | | 4,945 | | | | 4,945 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2027 | | | 5,000 | | | | 4,945 | | | | 4,945 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2027 | | | 5,000 | | | | 4,945 | | | | 4,945 | |
| SafelyYou, Inc. (2)(12) | | Software | | Term Loan | | | 11.00 | % | Prime | | | 3.25 | % | | | 11.00 | % | | | — | | | | 5.00 | % | June 1, 2027 | | | 5,000 | | | | 4,872 | | | | 4,872 | |
| | | | | Term Loan | | | 11.00 | % | Prime | | | 3.25 | % | | | 11.00 | % | | | — | | | | 5.00 | % | June 1, 2027 | | | 5,000 | | | | 4,945 | | | | 4,945 | |
| GT Medical Technologies, Inc. (2)(12) | | Other Healthcare Services | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 4.00 | % | October 1, 2029 | | | 3,750 | | | | 3,595 | | | | 3,595 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 4.00 | % | October 1, 2029 | | | 3,750 | | | | 3,695 | | | | 3,695 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 4.00 | % | October 1, 2029 | | | 7,500 | | | | 7,389 | | | | 7,389 | |
| Hometeam Technologies, Inc. (2)(12) | | Other Healthcare Services | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | August 1, 2029 | | | 5,000 | | | | 4,854 | | | | 4,854 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | August 1, 2029 | | | 5,000 | | | | 4,954 | | | | 4,954 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | August 1, 2029 | | | 5,000 | | | | 4,954 | | | | 4,954 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | August 1, 2029 | | | 5,000 | | | | 4,954 | | | | 4,954 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | August 1, 2029 | | | 5,000 | | | | 4,954 | | | | 4,954 | |
| Total Non-Affiliate Debt Investments — Healthcare information and services | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 106,940 | | | | 104,189 | |
| Total Non- Affiliate Debt Investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 660,556 | | | $ | 631,111 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Non-Affiliate Warrant Investments — 5.4% (8) | | | | | | | | | | | | | | | | |
| Non-Affiliate Warrants — Life Science — 1.9% (8) | | | | | | | | | | | | | | | | |
| Avalo Therapeutics, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 117 | | | $ | 311 | | | $ | — | |
| Castle Creek Biosciences, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 7,404 | | | | 214 | | | | 270 | |
| Emalex Biosciences, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 110,402 | | | | 176 | | | | 129 | |
| Imunon, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 19,671 | | | | 65 | | | | — | |
| KSQ Therapeutics, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 48,076 | | | | 50 | | | | 53 | |
| Mustang Bio, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 16,611 | | | | 146 | | | | — | |
| Native Microbials, Inc (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 112,879 | | | | 73 | | | | 68 | |
| PDS Biotechnology Corporation (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 299,848 | | | | 160 | | | | 14 | |
| Provivi, Inc. (2)(12) | | Biotechnology | | Common Stock Warrant | | | 175,098 | | | | 278 | | | | — | |
| Provivi, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 709,980 | | | | 312 | | | | 59 | |
| Stealth Biotherapeutics Inc. (2)(12) | | Biotechnology | | Common Stock Warrant | | | 318,181 | | | | 264 | | | | — | |
| Tallac Therapeutics, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 1,600,002 | | | | 194 | | | | 167 | |
| Xeris Pharmaceuticals, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 126,000 | | | | 73 | | | | 91 | |
| AccuVein Inc. (2)(12) | | Medical Device | | Common Stock Warrant | | | 271 | | | | 7 | | | | — | |
| Aerin Medical, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 1,818,183 | | | | 65 | | | | 1,418 | |
| Aerobiotix, LLC (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 8,800 | | | | 48 | | | | 16 | |
| Canary Medical Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 12,153 | | | | 86 | | | | 2 | |
| Candesant Biomedical, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 93,336 | | | | 152 | | | | 78 | |
| Ceribell, Inc. (2)(5)(12) | | Medical Device | | Preferred Stock Warrant | | | 89,903 | | | | 147 | | | | 1,573 | |
| Cognoa, Inc. (2)(12) | | Medical Device | | Common Stock Warrant | | | 30,585 | | | | — | | | | 2 | |
| Cognoa, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 4,635,991 | | | | 162 | | | | 1 | |
| Conventus Orthopaedics, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 9,313,541 | | | | 256 | | | | 102 | |
| CSA Medical, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 4,917,794 | | | | 174 | | | | 479 | |
| CVRx, Inc. (2)(5)(12) | | Medical Device | | Common Stock Warrant | | | 47,410 | | | | 76 | | | | 160 | |
| Infobionic, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 5,361,130 | | | | 231 | | | | 175 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Magnolia Medical Technologies, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 809,931 | | | | 194 | | | | 368 | |
| Meditrina, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 233,993 | | | | 83 | | | | 34 | |
| Mobia Medical, Inc. fka Microtransponder, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 103,172 | | | | 47 | | | | 66 | |
| Onkos Surgical, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 443,674 | | | | 192 | | | | 187 | |
| Scientia Vascular, Inc (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 34,410 | | | | 103 | | | | 262 | |
| Sonex Health, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 2,637,133 | | | | 275 | | | | 266 | |
| VERO Biotech LLC (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 3,701 | | | | 376 | | | | 198 | |
| Spineology, Inc. (2)(12) | | Medical Device | | Common Stock Warrant | | | 2,714,033 | | | | 143 | | | | 108 | |
| Spineology, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 2,255,155 | | | | 16 | | | | 28 | |
| Total Non-Affiliate Warrants — Life Science | | | | | | | 5,149 | | | | 6,374 | |
| Non-Affiliate Warrants — Sustainability — 0.1% (8) | | | | | | | | | | | | | | | | |
| New Aerofarms, Inc. assignee of Aerofarms, Inc. (2)(12)(14) | | Other Sustainability | | Preferred Stock Warrant | | | 400,000 | | | | 82 | | | | 17 | |
| LiquiGlide, Inc. (2)(12) | | Other Sustainability | | Preferred Stock Warrant | | | 61,359 | | | | 39 | | | | 25 | |
| Soli Organic, Inc. (2)(12) | | Other Sustainability | | Common Stock Warrant | | | 296 | | | | 20 | | | | 19 | |
| Soli Organic, Inc. (2)(12) | | Other Sustainability | | Preferred Stock Warrant | | | 1,075 | | | | 382 | | | | 10 | |
| Temperpack Technologies, Inc. (2)(12) | | Other Sustainability | | Preferred Stock Warrant | | | 49,693 | | | | 178 | | | | 102 | |
| Pivot Bio, Inc. (2)(12) | | Energy Efficiency | | Preferred Stock Warrant | | | 210,418 | | | | 14 | | | | 14 | |
| Total Non-Affiliate Warrants — Sustainability | | | | | | | 715 | | | | 187 | |
| Non-Affiliate Warrants — Technology — 3.1% (8) | | | | | | | | | | | | | | | | |
| Axiom Space Holdings, Inc. (2)(12) | | Communications | | Common Stock Warrant | | | 1,991 | | | | 46 | | | | 35 | |
| Intelepeer Holdings, Inc. (2)(12) | | Communications | | Preferred Stock Warrant | | | 2,936,535 | | | | 138 | | | | 3,156 | |
| Alula Holdings, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 20,000 | | | | 93 | | | | 7 | |
| CAMP NYC, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 112,356 | | | | 36 | | | | 40 | |
| Clara Foods Co. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 46,745 | | | | 30 | | | | 43 | |
| Divergent Technologies, Inc. (2)(12) | | Consumer-related Technologies | | Common Stock Warrant | | | 9,801 | | | | 79 | | | | 7 | |
| Divergent Technologies, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 45,273 | | | | 454 | | | | 440 | |
| Havenly, Inc. (2)(12) | | Consumer-related Technologies | | Common Stock Warrant | | | 1,446,429 | | | | 3,178 | | | | 3,106 | |
| MyForest Foods Co. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 250 | | | | 29 | | | | 25 | |
| NextCar Holding Company, Inc. (2)(12) | | Consumer-related Technologies | | Common Stock Warrant | | | 12,618 | | | | 188 | | | | — | |
| NextCar Holding Company, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 3,913,723 | | | | 9 | | | | — | |
| Optoro, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 11,550 | | | | 182 | | | | 99 | |
| Primary Kids, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 553,778 | | | | 57 | | | | 412 | |
| Quip NYC Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 6,191 | | | | 325 | | | | — | |
| Standvast Holdings, LLC (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 1,225,492 | | | | 275 | | | | — | |
| Unagi, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 171,081 | | | | 32 | | | | — | |
| Updater, Inc.(2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 108,333 | | | | 34 | | | | 26 | |
| CPG Beyond, Inc. (2)(12) | | Data Storage | | Preferred Stock Warrant | | | 500,000 | | | | 242 | | | | 231 | |
| Silk, Inc. (2)(12) | | Data Storage | | Preferred Stock Warrant | | | 394,110 | | | | 175 | | | | 119 | |
| Global Worldwide LLC (2)(12) | | Internet and Media | | Preferred Stock Warrant | | | 245,810 | | | | 75 | | | | — | |
| Rocket Lawyer Incorporated (2)(12) | | Internet and Media | | Preferred Stock Warrant | | | 261,721 | | | | 92 | | | | 319 | |
| Skillshare, Inc. (2)(12) | | Internet and Media | | Preferred Stock Warrant | | | 139,074 | | | | 162 | | | | 680 | |
| Liqid, Inc. (2)(12) | | Networking | | Preferred Stock Warrant | | | 344,102 | | | | 364 | | | | 103 | |
| Fictiv, Inc. (2)(12) | | Networking | | Common Stock Warrant | | | 126,841 | | | | 59 | | | | 77 | |
| Avalanche Technology, Inc. (2)(12) | | Semiconductors | | Preferred Stock Warrant | | | 5,938 | | | | 45 | | | | — | |
| BriteCore Holdings, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 161,215 | | | | 98 | | | | 289 | |
| Crafty Holdings, Inc. (2)(12) | | Software | | Common Stock Warrant | | | 243,278 | | | | 132 | | | | 132 | |
| Dropoff, Inc. (2)(12) | | Software | | Common Stock Warrant | | | 516,535 | | | | 455 | | | | — | |
| E La Carte, Inc. (2)(5)(12) | | Software | | Common Stock Warrant | | | 147,361 | | | | 60 | | | | — | |
| Everstream Holdings, LLC (2)(12) | | Software | | Preferred Stock Warrant | | | 525,000 | | | | 82 | | | | 34 | |
| Kodiak Robotics, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 639,918 | | | | 273 | | | | 15 | |
| Lemongrass Holdings, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 101,308 | | | | 34 | | | | 48 | |
| Mirantis, Inc. (2)(12) | | Software | | Common Stock Warrant | | | 948,275 | | | | 223 | | | | 585 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Noodle Partners, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 84,037 | | | | 116 | | | | — | |
| OneNetworks, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 184,646 | | | | 3 | | | | 3 | |
| Revinate Holdings, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 682,034 | | | | 44 | | | | 90 | |
| SIGNiX, Inc. (12) | | Software | | Preferred Stock Warrant | | | 186,235 | | | | 225 | | | | — | |
| Slingshot Aerospace, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 309,208 | | | | 123 | | | | 66 | |
| Supply Network Visibility Holdings LLC (2)(12) | | Software | | Preferred Stock Warrant | | | 682 | | | | 65 | | | | 75 | |
| Topia Mobility, Inc. (2)(12) | | Software | | Common Stock Warrant | | | 30,496 | | | | 138 | | | | — | |
| Ursa Space Systems, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 1,075,072 | | | | 151 | | | | 148 | |
| Viken Detection Corporation (2)(12) | | Software | | Preferred Stock Warrant | | | 345,443 | | | | 120 | | | | 234 | |
| xAd, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 4,343,348 | | | | 177 | | | | 6 | |
| Total Non-Affiliate Warrants — Technology | | | | | | | 8,918 | | | | 10,650 | |
| Non-Affiliate Warrants — Healthcare information and services — 0.3% (8) | | | | | | | | | | | | | | | | |
| Hound Labs, Inc (12) | | Diagnostics | | Preferred Stock Warrant | | | 451,796 | | | | 45 | | | | — | |
| Parse Biosciences, Inc. (2)(12) | | Diagnostics | | Common Stock Warrant | | | 32,244 | | | | 71 | | | | 15 | |
| Parse Biosciences, Inc. (2)(12) | | Diagnostics | | Preferred Stock Warrant | | | 184,253 | | | | 166 | | | | 15 | |
| Kate Farms, Inc. (2)(12) | | Other Healthcare | | Preferred Stock Warrant | | | 82,965 | | | | 101 | | | | 700 | |
| GT Medical Technologies, Inc. (2)(12) | | Other Healthcare | | Preferred Stock Warrant | | | 195,984 | | | | 83 | | | | 95 | |
| BrightInsight, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 85,066 | | | | 167 | | | | — | |
| Elligo Health Research, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 652,250 | | | | 191 | | | | 92 | |
| Medsphere Systems Corporation (2)(12) | | Software | | Preferred Stock Warrant | | | 7,097,792 | | | | 60 | | | | — | |
| SafelyYou, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 150,353 | | | | 163 | | | | 149 | |
| Total Non-Affiliate Warrants — Healthcare information and services | | | | | | | 1,047 | | | | 1,066 | |
| Total Non-Affiliate Warrants | | | | | | | 15,829 | | | | 18,277 | |
| Non-Affiliate Other Investments — Life Science — 0.0% (8) | | | | | | | | | | | | | | | | |
| Lumithera, Inc. (12) | | Medical Device | | Royalty Agreement | | | | | | | 1,146 | | | | 100 | |
| Robin Healthcare, Inc. (2)(12) | | Medical Device | | Royalty Agreement | | | | | | | 7,319 | | | | — | |
| Total Non-Affiliate Other Investments | | | | | | | 8,465 | | | | 100 | |
| Non-Affiliate Equity — 2.5% (8) | | | | | | | | | | | | | | | | |
| Cadrenal Therapeutics, Inc. (5) | | Biotechnology | | Common Stock | | | 40,000 | | | | — | | | | 580 | |
| Castle Creek Biosciences, Inc. (12) | | Biotechnology | | Common Stock | | | 1,162 | | | | 250 | | | | 250 | |
| Emalex Biosciences, Inc. (12) | | Biotechnology | | Preferred Stock | | | 32,831 | | | | 356 | | | | 356 | |
| Axiom Space, Inc. (12) | | Communications | | Preferred Stock | | | 1,810 | | | | 261 | | | | 306 | |
| PebblePost, Inc. (2)(12) | | Communications | | Preferred Stock | | | 56,212 | | | | 73 | | | | 73 | |
| Caastle, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock | | | 242,180 | | | | 2,681 | | | | 2,681 | |
| Getaround, Inc. (2)(5) | | Consumer-related Technologies | | Common Stock | | | 87,082 | | | | 253 | | | | 3 | |
| NextCar Holding Company, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock | | | 2,688,971 | | | | 89 | | | | — | |
| SnagAJob.com, Inc. (12) | | Consumer-related Technologies | | Common Stock | | | 82,974 | | | | 9 | | | | 83 | |
| Cognoa, Inc. (2)(12) | | Medical Device | | Common Stock | | | 8,123,877 | | | | 487 | | | | 487 | |
| Cognoa, Inc. (2)(12) | | Medical Device | | Preferred Stock | | | 1,059,636 | | | | 250 | | | | 250 | |
| Lumithera, Inc. (12) | | Medical Device | | Common Stock | | | 392,651 | | | | 2,000 | | | | 1,700 | |
| Tigo Energy, Inc. (5) | | Other Sustainability | | Common Stock | | | 5,205 | | | | 111 | | | | 5 | |
| Decisyon, Inc. (12) | | Software | | Preferred Stock | | | 280,000 | | | | 2,800 | | | | 1,281 | |
| Lotame, Inc. (12) | | Software | | Preferred Stock | | | 66,127 | | | | 4 | | | | 193 | |
| Lotame, Inc. (12) | | Software | | Preferred Stock | | | 9,381 | | | | 29 | | | | 29 | |
| Total Non-Affiliate Equity | | | | | | | 9,653 | | | | 8,277 | |
| Total Non-Affiliate Portfolio Investment Assets | | | | | | $ | 694,503 | | | $ | 657,765 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Non-Controlled Affiliate Investments — 2.5% (8) | | | | | | | | | | | | |
| Non-Controlled Affiliate Other Investments — 2.5% (8) | | | | | | | | | | | | |
| Evelo Holdings, Inc. (2)(5)(12)(16) | | Biotechnology | | Other Investment | | $ | 4,910 | | | $ | 1,825 | |
| | | | | Other Investment | | | 7,634 | | | | 2,832 | |
| | | | | Other Investment | | | 2,946 | | | | 1,095 | |
| | | | | Other Investment | | | 2,946 | | | | 1,095 | |
| | | | | Other Investment | | | 1,964 | | | | 730 | |
| | | | | Other Investment | | | 1,964 | | | | 730 | |
| Total Non-Controlled Affiliate Other Investments | | | 22,364 | | | | 8,307 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Non-controlled Affiliate Equity — 0.0% (8) | | | | | | | | | | | | | | | | |
| Aulea Medical, Inc. (12) | | Medical Device | | Common Stock | | | 660,537 | | | | — | | | | — | |
| Evelo Holdings, Inc. (2)(5)(12) | | Biotechnology | | Common Stock | | | 2,164,502 | | | | 5,000 | | | | — | |
| Total Non-Controlled Affiliate Equity | | | | | | | 5,000 | | | | — | |
| Non-controlled Affiliate Warrants — 0.0% (8) | | | | | | | | | | | | | | | | |
| Evelo Holdings, Inc. (2)(5)(12) | | Biotechnology | | Common Stock | | | 23,196 | | | | 127 | | | | — | |
| Total Non-Controlled Affiliate Warrants | | | | | | | 127 | | | | — | |
| Total Non-Controlled Affiliate Portfolio Investment Assets | | | | | | $ | 27,491 | | | $ | 8,307 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Controlled Affiliate Investments — 9.5% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Controlled Affiliate Debt Investments — 2.3% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Better Place Forests Co. (12)(13) | | Consumer-related Technologies | | Term Loan | | | 12.00% | (11) | Prime | | | 3.75 | % | | | 12.00 | % | | | — | | | | 2.78 | % | August 1, 2029 | | $ | 4,012 | | | $ | 4,058 | | | $ | — | |
| | | | | Term Loan | | | 12.00% | (11) | Prime | | | 3.75 | % | | | 12.00 | % | | | — | | | | 2.78 | % | August 1, 2029 | | | 2,006 | | | | 1,989 | | | | — | |
| | | | | Term Loan | | | 12.00% | (11) | Prime | | | 3.75 | % | | | 12.00 | % | | | — | | | | — | | August 1, 2025 | | | 538 | | | | 538 | | | | — | |
| | | | | Term Loan | | | 12.00% | (11) | Prime | | | 3.75 | % | | | 12.00 | % | | | — | | | | — | | August 1, 2025 | | | 532 | | | | 532 | | | | — | |
| | | | | Term Loan | | | 12.00% | (11) | Prime | | | 3.75 | % | | | 12.00 | % | | | — | | | | — | | August 1, 2025 | | | 521 | | | | 521 | | | | — | |
| | | | | Term Loan | | | 12.00% | (11) | Prime | | | 3.75 | % | | | 12.00 | % | | | — | | | | — | | August 1, 2025 | | | 513 | | | | 513 | | | | — | |
| | | | | Term Loan | | | 12.00% | (11) | Prime | | | 3.75 | % | | | 12.00 | % | | | — | | | | — | | August 1, 2025 | | | 505 | | | | 505 | | | | — | |
| Nexii, Inc. (12) | | Other Sustainability | | Term Loan | | | 10.00 | % | Fixed | | | — | | | | — | | | | — | | | | — | | July 1, 2027 | | | 790 | | | | 790 | | | | 638 | |
| Swift Health Systems Inc. (2)(12) | | Medical Device | | Term Loan | | | 10.25% | (11) | Prime | | | 2.50 | % | | | 2.50 | % | | | — | | | | 9.14 | % | June 1, 2028 | | | 1,948 | | | | 1,925 | | | | 1,658 | |
| | | | | Term Loan | | | 10.25% | (11) | Prime | | | 2.50 | % | | | 2.50 | % | | | — | | | | 9.14 | % | June 1, 2028 | | | 1,948 | | | | 1,925 | | | | 1,658 | |
| | | | | Term Loan | | | 10.25% | (11) | Prime | | | 2.50 | % | | | 2.50 | % | | | — | | | | 9.14 | % | June 1, 2028 | | | 1,948 | | | | 1,922 | | | | 1,654 | |
| | | | | Term Loan | | | 10.25% | (11) | Prime | | | 2.50 | % | | | 2.50 | % | | | — | | | | 9.14 | % | June 1, 2028 | | | 1,948 | | | | 1,922 | | | | 1,654 | |
| | | | | Term Loan | | | 10.25% | (11) | Prime | | | 2.50 | % | | | 2.50 | % | | | — | | | | 100.00 | % | June 1, 2028 | | | 315 | | | | 315 | | | | 271 | |
| | | | | Term Loan | | | 10.25% | (11) | Prime | | | 2.50 | % | | | 2.50 | % | | | — | | | | 100.00 | % | June 1, 2028 | | | 156 | | | | 156 | | | | 135 | |
| Total Controlled Affiliate Debt Investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 17,611 | | | $ | 7,668 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Controlled Affiliate Equity — 5.3% (8) | | | | | | | | | | | | | | | | |
| Better Place Forests Co. (12) | | Consumer-related Technologies | | Common Stock | | | 2,278,272 | | | | 639 | | | | — | |
| Better Place Forests Co. (12) | | Consumer-related Technologies | | Preferred Stock | | | 5,350,142 | | | | 3,922 | | | | — | |
| Nexii, Inc. (2)(12) | | Other Sustainability | | Common Stock | | | 108,320 | | | | 3,297 | | | | — | |
| Nexii, Inc. (2)(12) | | Other Sustainability | | Preferred Stock | | | 542 | | | | 3,419 | | | | 7,909 | |
| Swift Health Systems Inc. (2)(12) | | Medical Device | | Preferred Stock | | | 3,588,505 | | | | 10,012 | | | | 10,012 | |
| Total Controlled Affiliate Equity | | | | | | | 21,289 | | | | 17,921 | |
| Controlled Affiliate Other Investments — 1.9% (8) | | | | | | | | | | | | | | | | |
| HIMV LLC (12)(15) | | Biotechnology | | Other Investment | | | | | | | 5,880 | | | | 6,230 | |
| Total Controlled Affiliate Other | | | | | | | 5,880 | | | | 6,230 | |
| Total Controlled Affiliate Portfolio Investment Assets | | | | | | | 44,780 | | | | 31,819 | |
| Total Portfolio Investment Assets — 207.6% (8) | | | | | | $ | 766,774 | | | $ | 697,891 | |
| Short Term Investments - Unrestricted Investments - 8.1% (8) | | | | | | | | |
| US Bank Money Market Deposit Account | | | 27,266 | | | | 27,266 | |
| Total Short Term Investments - Unrestricted Investments | | $ | 27,266 | | | $ | 27,266 | |
| | | | | | | | | |
| Short Term Investments - Restricted Investments - 1.0% (8) | | | | | | | | |
| US Bank Money Market Deposit Account | | | 3,338 | | | | 3,338 | |
| Total Short Term Investments - Restricted Investments | | $ | 3,338 | | | $ | 3,338 | |
|